June
Eli Lilly appoints Liam English for ACE region
Liam English is to join Eli Lilly & Company as an associate director for the Australian, Canadian and European (ACE) region
01 Jun 2011
Teva/Pfizer settle Neurontin suit
Teva Pharmaceutical has announced it has settled a patent dispute with Pfizer concerning generic versions of Pfizer's Neurontin (gabapentin) – a drug marketed for pain management and the treatment of epilepsy
01 Jun 2011
AZ's Brilinta approved in Canada
Health Canada has approved AstraZeneca's Brilinta to prevent blood clots in patients with acute coronary syndrome
01 Jun 2011
FDA warns about birth control pills
The US Food and Drug Administration has issued a safety review following links between birth control pills containing drospirenone and an increase in blood clots
01 Jun 2011
EMA drug communication reviewed
The European Medicines Agency's (EMA) communication strategy concerning the benefits and risks of medicines has been put under the spotlight by an independent report
01 Jun 2011
GSK and MaRS launch innovation fund
GlaxoSmithKline and MaRS Innovation have set up a development fund that will support the commercialisation of translational research from 16 academic health science centres, hospitals and universities in Canada
01 Jun 2011
AVEO pens cancer development deal
AVEO Pharmaceuticals has agreed a deal with Centocor Ortho Biotech for the development of AVEO's internally-discovered antibodies targeting the RON receptor, which is responsible in several aspects of cancer
01 Jun 2011
BRIC doctors increase social networking
Physicians in the emerging BRIC countries are incorporating social networks and online communities into their professional resources, according to a study from Manhattan Research
01 Jun 2011
Pharmacoepidemiology standards published
The European Medicines Agency and the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance have published guidance on methodological standards in studying the effects of drugs in large groups of people
02 Jun 2011
EMA/HMA set drug application guidance
The European Medicines Agency and Heads of Medicines Agencies have released draft guidance detailing what information included in marketing authorisation applications for drugs can be released
02 Jun 2011